Findings of a clinic monitoring report released last week, again highlighted how delivery of health services in the Eastern Cape are hamstrung by staff and medicine shortages. Luvuyo Mehlwana unpacks the data and the provincial health department’s plans to address the challenges identified in the report.
Little is known about the number of people in South Africa who are living with rare diseases. In fact, there is no recognised definition for rare disease in the country, contributing to inadequate record-keeping and very little data on prevalence, treatment options, and support structures. Laura Owings reports.
Many clinics in Limpopo are operating without the required number of staff needed to deliver quality healthcare services, according to a report from Ritshidze, a community healthcare monitoring project. Activists say these staff shortages contribute to long waiting times for patients and overworked staff – which can ultimately undermine the province’s HIV programme.
Troubles regarding the placement of community service doctors have made headlines once again this year, as it seems to do most years. The structural roots of these problems are long-standing and complex. Elna Schütz unpacks the complexities and talks to role-players about possible solutions.
Medico-legal claims in the public healthcare sector have been sharply increasing since at least 2014 and are taking huge bites out of already stretched provincial budgets. Motheo Brodie and Sasha Stevenson of SECTION27 assess what impact a recent court judgment and proposed legislation might have on the problem.
When the history books are written, 2020 will be remembered as the year of COVID-19. But, in the world of health care, a lot of other things have happened, or not happened. We tried to summarise a tumultuous year in only 1 000 words.
The recent budget policy statement shows South Africa finds itself in a very tight fiscal space where it has to navigate a global pandemic along with other health challenges such as rising rates of non-communicable diseases. Russell Rensburg argues that the Health Promotion Levy should be increased to 20% – which will raise much-needed revenue that will contribute to preventing disease and reducing healthcare costs.